Anti-aging Market Size, Growth, Demands Outlook and Forecasts to 2030

According to the research report, the global anti-aging market size is expected to touch USD 119.6 Billion by 2030, from USD 64.99 Billion in 2022, growing with a significant CAGR of 7.9% from 2022 to 2030. 

The anti-aging report offers a comprehensive study of the current state expected at the major drivers, market strategies, and key vendors’ growth. The report presents energetic visions to conclude and study the market size, market hopes, and competitive surroundings. The research also focuses on the important achievements of the market, research & development, and regional growth of the leading competitors operating in the market. The current trends of the global anti-aging in conjunction with the geographical landscape of this vertical have also been included in this report.

The report offers intricate dynamics about different aspects of the global anti-aging market, which aids companies operating in the market in making strategic development decisions. The study also elaborates on significant changes that are highly anticipated to configure growth of the global anti-aging during the forecast period. It also includes a key indicator assessment that highlights growth prospects of this market and estimates statistics related to growth of the market in terms of value (US$ Mn) and volume (tons).

Sample Link @ https://www.precedenceresearch.com/sample/1597

 Report Scope of the Anti-aging Market

Report Coverage	Details
Market Size by 2030	USD 119.6 Billion
Growth Rate from 2022 to 2030	CAGR of 7.9%
Largest Market	North America
Fastest Growing Market	Asia Pacific
Base Year	2021
Forecast Period	2022 to 2030
Segments Covered	Product, Treatment, Demography, Devices, End User, Geography

This study covers a detailed segmentation of the global anti-aging market, along with key information and a competition outlook. The report mentions company profiles of players that are currently dominating the global anti-aging market, wherein various developments, expansions, and winning strategies practiced and implemented by leading players have been presented in detail.

Key Players

• Unilever Group
• GALDERMA LABORATORIES L.P.
• Procter & Gamble (P&G) Company
• Nu Skin Enterprises Inc.
• Hologic Inc.
• Pierre Fabre S.A.
• Shiseido Company Limited
• Candela Corporation
• Home Skinovations Ltd.
• Estee Lauder

Market Segmentation

 By Products

• Anti-wrinkle
• Hair color
• Ultraviolet absorption
• Anti-stretch mark

By Treatment

• Hair restoration
• Anti-pigmentation
• Adult acne therapy
• Breast augmentation
• Liposuction
• Chemical peel

By Demography

• Generation X
• Baby Boomers
• Generation Y
• Generation Z

By Devices

• Anti-cellulite treatment
• Laser aesthetic devices
• Microdermabrasion devices
• Radio frequency devices
• Others 

By End User

• Hospitals
• Clinics
• Home healthcare

By Geography

• North America
• U.S.
• Canada
• Europe
• U.K.
• Germany
• France
• Asia-Pacific
• China
• India
• Japan
• South Korea
• Malaysia
• Philippines
• Latin America
• Brazil
• Rest of Latin America
• Middle East & Africa (MEA)
• GCC
• North Africa
• South Africa
• Rest of the Middle East & Africa

Research Methodology

The research methodology adopted by analysts for compiling the global anti-aging report is based on detailed primary as well as secondary research. With the help of in-depth insights of the market-affiliated information that is obtained and legitimated by market-admissible resources, analysts have offered riveting observations and authentic forecasts for the global market.

During the primary research phase, analysts interviewed market stakeholders, investors, brand managers, vice presidents, and sales and marketing managers. Based on data obtained through interviews of genuine resources, analysts have emphasized the changing scenario of the global market.

For secondary research, analysts scrutinized numerous annual report publications, white papers, market association publications, and company websites to obtain the necessary understanding of the global anti-aging market.

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Anti-aging Market 

5.1. COVID-19 Landscape: Anti-aging Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Anti-aging Market, By Products Type

8.1. Anti-aging Market, by Products Type, 2022-2030

8.1.1. Anti-wrinkle

8.1.1.1. Market Revenue and Forecast (2017-2030)

8.1.2. Hair color

8.1.2.1. Market Revenue and Forecast (2017-2030)

8.1.3. Ultraviolet absorption

8.1.3.1. Market Revenue and Forecast (2017-2030)

8.1.4. Anti-stretch mark

8.1.4.1. Market Revenue and Forecast (2017-2030)

Chapter 9. Global Anti-aging Market, By Treatment Type

9.1. Anti-aging Market, by Treatment Type, 2022-2030

9.1.1. Hair restoration

9.1.1.1. Market Revenue and Forecast (2017-2030)

9.1.2. Anti-pigmentation

9.1.2.1. Market Revenue and Forecast (2017-2030)

9.1.3. Adult acne therapy

9.1.3.1. Market Revenue and Forecast (2017-2030)

9.1.4. Breast augmentation

9.1.4.1. Market Revenue and Forecast (2017-2030)

9.1.5. Liposuction

9.1.5.1. Market Revenue and Forecast (2017-2030)

9.1.6. Chemical Peel

9.1.6.1. Market Revenue and Forecast (2017-2030)

Chapter 10. Global Anti-aging Market, By Demography Type 

10.1. Anti-aging Market, by Demography Type, 2022-2030

10.1.1. Generation X

10.1.1.1. Market Revenue and Forecast (2017-2030)

10.1.2. Baby Boomers

10.1.2.1. Market Revenue and Forecast (2017-2030)

10.1.3. Generation Y

10.1.3.1. Market Revenue and Forecast (2017-2030)

10.1.4. Generation Z

10.1.4.1. Market Revenue and Forecast (2017-2030)

Chapter 11. Global Anti-aging Market, By Devices Type

11.1. Anti-aging Market, by Devices Type, 2022-2030

11.1.1. Anti-cellulite treatment

11.1.1.1. Market Revenue and Forecast (2017-2030)

11.1.2. Laser aesthetic devices

11.1.2.1. Market Revenue and Forecast (2017-2030)

11.1.3. Microdermabrasion devices

11.1.3.1. Market Revenue and Forecast (2017-2030)

11.1.4. Radio frequency devices

11.1.4.1. Market Revenue and Forecast (2017-2030)

11.1.5. Others

11.1.5.1. Market Revenue and Forecast (2017-2030)

Chapter 12. Global Anti-aging Market, By End User Type

12.1. Anti-aging Market, by End User, 2022-2030

12.1.1. Hospitals

12.1.1.1. Market Revenue and Forecast (2017-2030)

12.1.2. Clinics

12.1.2.1. Market Revenue and Forecast (2017-2030)

12.1.3. Home healthcare

12.1.3.1. Market Revenue and Forecast (2017-2030)

Chapter 13. Global Anti-aging  Market, Regional Estimates and Trend Forecast

13.1. North America

13.1.1. Market Revenue and Forecast, by Products (2017-2030)

13.1.2. Market Revenue and Forecast, by Treatment (2017-2030)

13.1.3. Market Revenue and Forecast, by Demography (2017-2030)

13.1.4. Market Revenue and Forecast, by Devices (2017-2030)

13.1.5. Market Revenue and Forecast, by End User (2017-2030)

13.1.6. U.S.

13.1.6.1. Market Revenue and Forecast, by Products (2017-2030)

13.1.6.2. Market Revenue and Forecast, by Treatment (2017-2030)

13.1.6.3. Market Revenue and Forecast, by Demography (2017-2030)

13.1.6.4. Market Revenue and Forecast, by Devices (2017-2030)

13.1.7. Market Revenue and Forecast, by End User (2017-2030) 

13.1.8. Rest of North America

13.1.8.1. Market Revenue and Forecast, by Products (2017-2030)

13.1.8.2. Market Revenue and Forecast, by Treatment (2017-2030)

13.1.8.3. Market Revenue and Forecast, by Demography (2017-2030)

13.1.8.4. Market Revenue and Forecast, by Devices (2017-2030)

13.1.8.5. Market Revenue and Forecast, by End User (2017-2030)

13.2. Europe

13.2.1. Market Revenue and Forecast, by Products (2017-2030)

13.2.2. Market Revenue and Forecast, by Treatment (2017-2030)

13.2.3. Market Revenue and Forecast, by Demography (2017-2030)

13.2.4. Market Revenue and Forecast, by Devices (2017-2030) 

13.2.5. Market Revenue and Forecast, by End User (2017-2030) 

13.2.6. UK

13.2.6.1. Market Revenue and Forecast, by Products (2017-2030)

13.2.6.2. Market Revenue and Forecast, by Treatment (2017-2030)

13.2.6.3. Market Revenue and Forecast, by Demography (2017-2030)

13.2.7. Market Revenue and Forecast, by Devices (2017-2030) 

13.2.8. Market Revenue and Forecast, by End User (2017-2030) 

13.2.9. Germany

13.2.9.1. Market Revenue and Forecast, by Products (2017-2030)

13.2.9.2. Market Revenue and Forecast, by Treatment (2017-2030)

13.2.9.3. Market Revenue and Forecast, by Demography (2017-2030)

13.2.10. Market Revenue and Forecast, by Devices (2017-2030)

13.2.11. Market Revenue and Forecast, by End User (2017-2030)

13.2.12. France

13.2.12.1. Market Revenue and Forecast, by Products (2017-2030)

13.2.12.2. Market Revenue and Forecast, by Treatment (2017-2030)

13.2.12.3. Market Revenue and Forecast, by Demography (2017-2030)

13.2.12.4. Market Revenue and Forecast, by Devices (2017-2030)

13.2.13. Market Revenue and Forecast, by End User (2017-2030)

13.2.14. Rest of Europe

13.2.14.1. Market Revenue and Forecast, by Products (2017-2030)

13.2.14.2. Market Revenue and Forecast, by Treatment (2017-2030)

13.2.14.3. Market Revenue and Forecast, by Demography (2017-2030)

13.2.14.4. Market Revenue and Forecast, by Devices (2017-2030)

13.2.15. Market Revenue and Forecast, by End User (2017-2030)

13.3. APAC

13.3.1. Market Revenue and Forecast, by Products (2017-2030)

13.3.2. Market Revenue and Forecast, by Treatment (2017-2030)

13.3.3. Market Revenue and Forecast, by Demography (2017-2030)

13.3.4. Market Revenue and Forecast, by Devices (2017-2030)

13.3.5. Market Revenue and Forecast, by End User (2017-2030)

13.3.6. India

13.3.6.1. Market Revenue and Forecast, by Products (2017-2030)

13.3.6.2. Market Revenue and Forecast, by Treatment (2017-2030)

13.3.6.3. Market Revenue and Forecast, by Demography (2017-2030)

13.3.6.4. Market Revenue and Forecast, by Devices (2017-2030)

13.3.7. Market Revenue and Forecast, by End User (2017-2030)

13.3.8. China

13.3.8.1. Market Revenue and Forecast, by Products (2017-2030)

13.3.8.2. Market Revenue and Forecast, by Treatment (2017-2030)

13.3.8.3. Market Revenue and Forecast, by Demography (2017-2030)

13.3.8.4. Market Revenue and Forecast, by Devices (2017-2030)

13.3.9. Market Revenue and Forecast, by End User (2017-2030)

13.3.10. Japan

13.3.10.1. Market Revenue and Forecast, by Products (2017-2030)

13.3.10.2. Market Revenue and Forecast, by Treatment (2017-2030)

13.3.10.3. Market Revenue and Forecast, by Demography (2017-2030)

13.3.10.4. Market Revenue and Forecast, by Devices (2017-2030)

13.3.10.5. Market Revenue and Forecast, by End User (2017-2030)

13.3.11. Rest of APAC

13.3.11.1. Market Revenue and Forecast, by Products (2017-2030)

13.3.11.2. Market Revenue and Forecast, by Treatment (2017-2030)

13.3.11.3. Market Revenue and Forecast, by Demography (2017-2030)

13.3.11.4. Market Revenue and Forecast, by Devices (2017-2030)

13.3.11.5. Market Revenue and Forecast, by End User (2017-2030)

13.4. MEA

13.4.1. Market Revenue and Forecast, by Products (2017-2030)

13.4.2. Market Revenue and Forecast, by Treatment (2017-2030)

13.4.3. Market Revenue and Forecast, by Demography (2017-2030)

13.4.4. Market Revenue and Forecast, by Devices (2017-2030)

13.4.5. Market Revenue and Forecast, by End User (2017-2030)

13.4.6. GCC

13.4.6.1. Market Revenue and Forecast, by Products (2017-2030)

13.4.6.2. Market Revenue and Forecast, by Treatment (2017-2030)

13.4.6.3. Market Revenue and Forecast, by Demography (2017-2030)

13.4.6.4. Market Revenue and Forecast, by Devices (2017-2030)

13.4.7. Market Revenue and Forecast, by End User (2017-2030)

13.4.8. North Africa

13.4.8.1. Market Revenue and Forecast, by Products (2017-2030)

13.4.8.2. Market Revenue and Forecast, by Treatment (2017-2030)

13.4.8.3. Market Revenue and Forecast, by Demography (2017-2030)

13.4.8.4. Market Revenue and Forecast, by Devices (2017-2030)

13.4.9. Market Revenue and Forecast, by End User (2017-2030)

13.4.10. South Africa

13.4.10.1. Market Revenue and Forecast, by Products (2017-2030)

13.4.10.2. Market Revenue and Forecast, by Treatment (2017-2030)

13.4.10.3. Market Revenue and Forecast, by Demography (2017-2030)

13.4.10.4. Market Revenue and Forecast, by Devices (2017-2030)

13.4.10.5. Market Revenue and Forecast, by End User (2017-2030)

13.4.11. Rest of MEA

13.4.11.1. Market Revenue and Forecast, by Products (2017-2030)

13.4.11.2. Market Revenue and Forecast, by Treatment (2017-2030)

13.4.11.3. Market Revenue and Forecast, by Demography (2017-2030)

13.4.11.4. Market Revenue and Forecast, by Devices (2017-2030)

13.4.11.5. Market Revenue and Forecast, by End User (2017-2030)

13.5. Latin America

13.5.1. Market Revenue and Forecast, by Products (2017-2030)

13.5.2. Market Revenue and Forecast, by Treatment (2017-2030)

13.5.3. Market Revenue and Forecast, by Demography (2017-2030)

13.5.4. Market Revenue and Forecast, by Devices (2017-2030)

13.5.5. Market Revenue and Forecast, by End User (2017-2030)

13.5.6. Brazil

13.5.6.1. Market Revenue and Forecast, by Products (2017-2030)

13.5.6.2. Market Revenue and Forecast, by Treatment (2017-2030)

13.5.6.3. Market Revenue and Forecast, by Demography (2017-2030)

13.5.6.4. Market Revenue and Forecast, by Devices (2017-2030)

13.5.7. Market Revenue and Forecast, by End User (2017-2030)

13.5.8. Rest of LATAM

13.5.8.1. Market Revenue and Forecast, by Products (2017-2030)

13.5.8.2. Market Revenue and Forecast, by Treatment (2017-2030)

13.5.8.3. Market Revenue and Forecast, by Demography (2017-2030)

13.5.8.4. Market Revenue and Forecast, by Devices (2017-2030)

13.5.8.5. Market Revenue and Forecast, by End User (2017-2030)

Chapter 14. Company Profiles

14.1. Unilever Group

14.1.1. Company Overview

14.1.2. Product Offerings

14.1.3. Financial Performance

14.1.4. Recent Initiatives

14.2. GALDERMA LABORATORIES L.P.

14.2.1. Company Overview

14.2.2. Product Offerings

14.2.3. Financial Performance

14.2.4. Recent Initiatives

14.3. Procter & Gamble (P&G) Company

14.3.1. Company Overview

14.3.2. Product Offerings

14.3.3. Financial Performance

14.3.4. Recent Initiatives

14.4. Nu Skin Enterprises Inc.

14.4.1. Company Overview

14.4.2. Product Offerings

14.4.3. Financial Performance

14.4.4. Recent Initiatives

14.5. Hologic Inc.

14.5.1. Company Overview

14.5.2. Product Offerings

14.5.3. Financial Performance

14.5.4. Recent Initiatives

14.6. Pierre Fabre S.A.

14.6.1. Company Overview

14.6.2. Product Offerings

14.6.3. Financial Performance

14.6.4. Recent Initiatives

14.7. Shiseido Company Limited

14.7.1. Company Overview

14.7.2. Product Offerings

14.7.3. Financial Performance

14.7.4. Recent Initiatives

14.8. Candela Corporation

14.8.1. Company Overview

14.8.2. Product Offerings

14.8.3. Financial Performance

14.8.4. Recent Initiatives

14.9. Home Skinovations Ltd.

14.9.1. Company Overview

14.9.2. Product Offerings

14.9.3. Financial Performance

14.9.4. Recent Initiatives

14.10. Estee Lauder

14.10.1. Company Overview

14.10.2. Product Offerings

14.10.3. Financial Performance

14.10.4. Recent Initiatives

Chapter 15. Research Methodology

15.1. Primary Research

15.2. Secondary Research

15.3. Assumptions

Chapter 16. Appendix

16.1. About Us

16.2. Glossary of Terms

Contact Us:

Precedence Research

Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada

Call: +1 774 402 6168

Email: sales@precedenceresearch.com

Website: https://www.precedenceresearch.com

 Blog: https://www.pharma-geek.com